{"id":"https://openalex.org/W4394479682","doi":"https://doi.org/10.6084/m9.figshare.19933722","title":"Seroprevalence of Toxoplasma gondii IgG antibody in HIV/AIDS-infected individuals in Maputo, Mozambique","display_name":"Seroprevalence of Toxoplasma gondii IgG antibody in HIV/AIDS-infected individuals in Maputo, Mozambique","publication_year":2022,"publication_date":"2022-01-01","ids":{"openalex":"https://openalex.org/W4394479682","doi":"https://doi.org/10.6084/m9.figshare.19933722"},"language":"en","primary_location":{"id":"pmh:oai:figshare.com:article/19933722","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Seroprevalence_of_Toxoplasma_gondii_IgG_antibody_in_HIV_AIDS-infected_individuals_in_Maputo_Mozambique/19933722","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"volume":null,"type":"dataset","is_traditional":false,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/dataset/Seroprevalence_of_Toxoplasma_gondii_IgG_antibody_in_HIV_AIDS-infected_individuals_in_Maputo_Mozambique/19933722","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006889704","display_name":"A. Oliveira Domingos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Domingos, Ab\u00edlio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039863063","display_name":"Lucy S. Ito","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ito, Lucy Sayuri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Coelho, Elizabeth","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Coelho, Elizabeth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047259428","display_name":"Jorge Manuel L\u00facio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L\u00facio, Jorge Manuel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020306331","display_name":"Luiza Harunari Matida","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matida, Luiza Harunari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5068781093","display_name":"Alberto Novaes Ramos","orcid":"https://orcid.org/0000-0001-7982-1757","observed_orcids":["https://orcid.org/0000-0001-7982-1757"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ramos Jr, Alberto Novaes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11155","display_name":"Toxoplasma gondii Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2405","display_name":"Parasitology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11155","display_name":"Toxoplasma gondii Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2405","display_name":"Parasitology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11154","display_name":"Parasitic infections in humans and animals","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2405","display_name":"Parasitology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11086","display_name":"Parasitic Infections and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2405","display_name":"Parasitology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/toxoplasma-gondii","display_name":"Toxoplasma gondii","score":0.9980000257492065},{"id":"https://openalex.org/keywords/toxoplasmosis","display_name":"toxoplasmosis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/seroprevalence","display_name":"seroprevalence","score":0.9490000009536743},{"id":"https://openalex.org/keywords/hiv-aids","display_name":"HIV/AIDS","score":0.7919999957084656},{"id":"https://openalex.org/keywords/igg","display_name":"IgG","score":0.9589999914169312},{"id":"https://openalex.org/keywords/latent-infection","display_name":"latent infection","score":0.656000018119812},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.9210000038146973},{"id":"https://openalex.org/keywords/soil-contact","display_name":"soil contact","score":0.7649999856948853},{"id":"https://openalex.org/keywords/meningoencephalitis","display_name":"meningoencephalitis","score":0.8410000205039978},{"id":"https://openalex.org/keywords/maputo-mozambique","display_name":"Maputo, Mozambique","score":0.7900000214576721}],"concepts":[{"id":"https://openalex.org/C2778494684","wikidata":"https://www.wikidata.org/wiki/Q3511357","display_name":"Seroprevalence","level":4,"score":0.933432936668396},{"id":"https://openalex.org/C2778128430","wikidata":"https://www.wikidata.org/wiki/Q131003","display_name":"Toxoplasma gondii","level":3,"score":0.7365570068359375},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.7341338396072388},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5910606980323792},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4731489419937134},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.46737140417099},{"id":"https://openalex.org/C2778062946","wikidata":"https://www.wikidata.org/wiki/Q154878","display_name":"Toxoplasmosis","level":2,"score":0.46455496549606323},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4382254183292389},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3271716237068176},{"id":"https://openalex.org/C45189115","wikidata":"https://www.wikidata.org/wiki/Q502159","display_name":"Serology","level":3,"score":0.24977520108222961}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:figshare.com:article/19933722","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Seroprevalence_of_Toxoplasma_gondii_IgG_antibody_in_HIV_AIDS-infected_individuals_in_Maputo_Mozambique/19933722","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.19933722","doi":"https://doi.org/10.6084/m9.figshare.19933722","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.19933722","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.19933722.v1","doi":"https://doi.org/10.6084/m9.figshare.19933722.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.19933722.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/19933722","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Seroprevalence_of_Toxoplasma_gondii_IgG_antibody_in_HIV_AIDS-infected_individuals_in_Maputo_Mozambique/19933722","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4410994680","https://openalex.org/W2406859201","https://openalex.org/W2065251102","https://openalex.org/W2054386060","https://openalex.org/W2135195513","https://openalex.org/W4304187862","https://openalex.org/W2801401281","https://openalex.org/W4401495475","https://openalex.org/W2407301318","https://openalex.org/W7220475631"],"abstract_inverted_index":{"OBJECTIVE":[0],"To":[1],"analyze":[2],"the":[3,17,30,79,198,208],"prevalence":[4,128,190],"of":[5,19,32,38,72,81,86,129,180,211],"IgG":[6,70,87],"antibodies":[7],"to":[8,122],"Toxoplasma":[9],"gondii":[10,75,90],"in":[11,45,49,52,98,104,131,191,204,219],"patients":[12,40,220],"infected":[13,41],"with":[14,42,61,106,125,136,166,178,188,216,221],"HIV/AIDS":[15,43],"and":[16,21,35,100,162,194,213],"association":[18],"demographic":[20],"social":[22],"variables.":[23],"METHODS":[24],"Descriptive":[25],"cross-sectional":[26],"study":[27],"that":[28],"included":[29],"analysis":[31,80],"sociodemographic":[33],"data":[34,55],"laboratory":[36,47],"findings":[37],"200":[39],"treated":[44],"a":[46,62,126],"unit":[48],"Maputo,":[50],"Mozambique,":[51],"2010.":[53],"Individual":[54],"for":[56,69,78],"all":[57],"participants":[58],"were":[59,67,175],"collected":[60],"self-administered":[63],"questionnaire.":[64],"Plasma":[65],"samples":[66],"tested":[68],"testing":[71],"anti-":[73,88],"T.":[74,89],"using":[76],"hemagglutination":[77],"antibodies.":[82],"RESULTS":[83],"The":[84],"seroprevalence":[85],"was":[91],"46.0%":[92],"(95%CI":[93,96,102],"39.2;52.9),":[94],"39.3%":[95],"29.5;50.0)":[97],"men":[99],"50.9%":[101],"41.9;59.8)":[103],"women,":[105],"no":[107,137],"difference":[108,139],"between":[109,140],"sex":[110],"(OR":[111,146,155,168],"1.30;":[112],"95%CI":[113,148,157,170],"0.95;1.77;":[114],"p":[115,150,159,172],"=":[116,151],"0.12).":[117],"Ages":[118],"ranged":[119],"from":[120],"10":[121],"60":[123],"years,":[124],"higher":[127],"infection":[130,187],"older":[132],"age":[133],"groups,":[134],"but":[135],"significant":[138],"them.":[141],"Regularly":[142],"consuming":[143],"cattle":[144],"meat":[145],"1.74;":[147],"1.04;2.89,":[149],"0.05),":[152],"breeding":[153],"cats/dogs":[154],"6.18;":[156],"3.60;10.62,":[158],"<":[160,173],"0.000)":[161,174],"having":[163],"regular":[164],"contact":[165],"soil":[167],"3.38;":[169],"2.19;5.21;":[171],"significantly":[176],"associated":[177,215],"risk":[179],"latent":[181],"infection.":[182],"CONCLUSIONS":[183],"Toxoplasmosis":[184,200],"is":[185],"an":[186],"high":[189],"Mozambique.":[192],"Cultural":[193],"behavioral":[195],"aspects":[196],"increase":[197],"risk.":[199],"can":[201],"be":[202],"responsible":[203],"our":[205],"environment":[206],"by":[207],"great":[209],"burden":[210],"morbidity":[212],"mortality":[214],"meningoencephalic":[217],"injuries":[218],"HIV/AIDS.":[222]},"counts_by_year":[],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2024-04-08T00:00:00"}